Real-time enrollment status for this glioblastoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 3:58 PM UTC
| NCT Number | NCT06613841 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 15 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | November 28, 2025 (Nov 28, 2025) |
As of July 18, 2026: Clinical trial NCT06613841 is currently recruiting participants. This early_phase1 study for glioblastoma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06613841 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06613841 was last updated Nov 28, 2025 (November 28, 2025). HelloStudys verifies this status automatically.